These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35260194)

  • 21. Phosphorylated α-synuclein and phosphorylated tau-protein in sural nerves may contribute to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear paralysis.
    Rong Z; Shen F; Wang Y; Sun L; Wu J; Zhang H; Yuan Y; Jiang W; Li X; Ji P; Zhang K
    Neurosci Lett; 2021 Jun; 756():135964. PubMed ID: 34022266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson's disease: an anatomical study.
    Ghebremedhin E; Del Tredici K; Langston JW; Braak H
    Acta Neuropathol; 2009 Dec; 118(6):777-84. PubMed ID: 19802627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson's disease.
    Tan Y; Sgobio C; Arzberger T; Machleid F; Tang Q; Findeis E; Tost J; Chakroun T; Gao P; Höllerhage M; Bötzel K; Herms J; Höglinger G; Koeglsperger T
    Acta Neuropathol; 2020 Feb; 139(2):319-345. PubMed ID: 31768670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From the Cover: Arsenic Induces Accumulation of α-Synuclein: Implications for Synucleinopathies and Neurodegeneration.
    Cholanians AB; Phan AV; Ditzel EJ; Camenisch TD; Lau SS; Monks TJ
    Toxicol Sci; 2016 Oct; 153(2):271-81. PubMed ID: 27413109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension ​.
    Isonaka R; Sullivan P; Holmes C; Goldstein DS
    Clin Auton Res; 2024 Jun; 34(3):329-339. PubMed ID: 38844644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction between Neuromelanin and Alpha-Synuclein in Parkinson's Disease.
    Xu S; Chan P
    Biomolecules; 2015 Jun; 5(2):1122-42. PubMed ID: 26057626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The diagnostic discrimination of cutaneous α-synuclein deposition in Parkinson disease.
    Gibbons CH; Garcia J; Wang N; Shih LC; Freeman R
    Neurology; 2016 Aug; 87(5):505-12. PubMed ID: 27385742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.
    Donadio V; Incensi A; Rizzo G; De Micco R; Tessitore A; Devigili G; Del Sorbo F; Bonvegna S; Infante R; Magnani M; Zenesini C; Vignatelli L; Cilia R; Eleopra R; Tedeschi G; Liguori R
    Mov Disord; 2020 Sep; 35(9):1649-1657. PubMed ID: 32557839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker.
    Visanji NP; Marras C; Hazrati LN; Liu LW; Lang AE
    Mov Disord; 2014 Apr; 29(4):444-50. PubMed ID: 24375496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated Alpha-Synuclein Within Cutaneous Autonomic Nerves of Patients With Parkinson's Disease: The Implications of Sample Thickness on Results.
    Wang N; Garcia J; Freeman R; Gibbons CH
    J Histochem Cytochem; 2020 Oct; 68(10):669-678. PubMed ID: 32921251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. α-mangostin derivative 4e as a PDE4 inhibitor promote proteasomal degradation of alpha-synuclein in Parkinson's disease models through PKA activation.
    Chen JY; Zhu Q; Cai CZ; Luo HB; Lu JH
    Phytomedicine; 2022 Jul; 101():154125. PubMed ID: 35525236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Synuclein real-time quaking-induced conversion in the submandibular glands of Parkinson's disease patients.
    Manne S; Kondru N; Jin H; Anantharam V; Huang X; Kanthasamy A; Kanthasamy AG
    Mov Disord; 2020 Feb; 35(2):268-278. PubMed ID: 31758740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
    Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
    J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of SNCA variants with α-synuclein of gastric and colonic mucosa in Parkinson's disease.
    Chung SJ; König IR; Lohmann K; Hinrichs F; Kim J; Ryu HS; Lee HJ; Kim K; Lee JH; Jung KW; Kim MJ; Kim MJ; Kim YJ; Yun SC; Hong SM; Myung SJ; Klein C
    Parkinsonism Relat Disord; 2019 Apr; 61():151-155. PubMed ID: 30424941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.
    Williams GP; Schonhoff AM; Jurkuvenaite A; Thome AD; Standaert DG; Harms AS
    J Neuroinflammation; 2018 Aug; 15(1):244. PubMed ID: 30165873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.
    Bougea A; Koros C; Stefanis L
    J Neural Transm (Vienna); 2019 Nov; 126(11):1373-1382. PubMed ID: 31401695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post mortem evaluation of inflammation, oxidative stress, and PPARγ activation in a nonhuman primate model of cardiac sympathetic neurodegeneration.
    Metzger JM; Matsoff HN; Zinnen AD; Fleddermann RA; Bondarenko V; Simmons HA; Mejia A; Moore CF; Emborg ME
    PLoS One; 2020; 15(1):e0226999. PubMed ID: 31910209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    Giannoccaro MP; Donadio V; Giannini G; Devigili G; Rizzo G; Incensi A; Cason E; Calandra-Buonaura G; Eleopra R; Cortelli P; Liguori R
    Parkinsonism Relat Disord; 2020 Dec; 81():48-53. PubMed ID: 33049589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy.
    Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C
    Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.